日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌患者的真实世界疗效:土耳其肿瘤协作组多中心研究

Sahin, Taha Koray; Kemik, Fatih; Muglu, Harun; Acikgöz Yildiz, Bedriye; Biter, Sedat; Tunbekici, Salih; Oruc, Ahmet; Guren, Ali Kaan; Kaban, Kerim; Guzel, Halil Goksel; Erol, Cihan; Aykan, Musa Baris; Koylu, Bahadir; Ekinci, Omer Burak; Deliktas Onur, Ilknur; Kalem, Ali; Altunok, Oguz; Seyyar, Mustafa; Guney, Bunyamin; Akdogan, Orhun; Ismayilov, Rashad; Ardic, Fadime Sinem; Yazici, Melike; Majidova, Nargiz; Turker, Sema; Esin, Ece; Cabuk, Devrim; Yasar, Hatime Arzu; Oguz, Arzu; Yazici, Ozan; Gursu, Riza Umar; Yılmaz, Mesut; Yesil Cinkir, Havva; Ates, Ozturk; Celik, Emir; Karadurmus, Nuri; Demirci, Umut; Ozturk, Banu; Mandel, Nil Molinas; Bayoglu, Ibrahim Vedat; Araz, Murat; Goker, Erdem; Bayram, Ertugrul; Erdem, Dilek; Selcukbiricik, Fatih; Basaran, Gul; Sezer, Ahmet; Dogu, Gamze Gokoz; Kemal, Yasemin; Bilici, Ahmet; Gunduz, Seyda; Guven, Deniz Can; Aksoy, Sercan

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

系统性炎症标志物在PD-L1 CPS评分≥5的转移性胃癌和胃食管交界处腺癌患者中的预后和预测价值:土耳其肿瘤协作组(TOG)研究

Mildanoglu, Maral Martin; Kutlu, Yasin; Bas, Onur; Koylu, Bahadır; Dae, Shute Ailia; Sakin, Abdullah; Erdem, Dilek; Sendur, Mehmet Ali Nahit; Tasci, Elif Senocak; Dane, Faysal; Kaya, Ali Osman; Aykan, Musa Baris; Ergun, Yakup; Biter, Sedat; Dizdar, Omer; Disel, Umut; Selcukbiricik, Fatih; Kose, Fatih; Olmez, Omer Fatih; Demir, Gokhan; Yalcin, Suayib; Bilici, Ahmet

Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey

转移性生殖细胞肿瘤的生存结果:一项来自土耳其的多中心研究

Yildiran Keskin, Gul Sema; Yetginoglu, Ozge; Vurgun, Sertac; Guzel, Evrican Zin; Ozkan, Fariz Emrah; Yilmaz, Mesut; Soylemez, Cem Murat; Agyol, Yesim; Akbas, Sinem; Sagiroglu, Muhammed Fatih; Yildirim, Gizem; Semiz, Huseyin Salih; Tatli, Ali Murat; Ekinci, Ferhat; Cosar, Ramazan; Acar, Ramazan; Aykan, Musa Baris; Erturk, Ismail; Karadurmus, Nuri

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

一线纳武利尤单抗联合化疗治疗晚期胃癌、胃食管交界处癌和食管腺癌患者的真实世界疗效和安全性:一项全国性土耳其肿瘤协作组(TOG)观察性研究

Kutlu, Yasin; Dae, Shute Ailia; Yilmaz, Feride; Erdem, Dilek; Sendur, Mehmet Ali Nahit; Akbas, Sinem; Senocak Tasci, Elif; Bas, Onur; Dane, Faysal; Sakin, Abdullah; Kaya, Ali Osman; Aykan, Musa Baris; Ergun, Yakup; Biter, Sedat; Disel, Umut; Korkmaz, Mustafa; Selcukbiricik, Fatih; Kose, Fatih; Olmez, Omer Fatih; Bilici, Ahmet; Demir, Gokhan; Yalcin, Suayib

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

CDK4/6抑制剂的活性及影响老年患者生存的因素在不同年龄亚组中的作用:土耳其肿瘤协作组(TOG)回顾性研究

Kahraman, Seda; Hizal, Mutlu; Demirel, Burcin Cakan; Guven, Deniz Can; Gumusay, Ozge; Uluc, Basak Oyan; Bayram, Ertugrul; Gulbagci, Burcu; Yasar, Alper; Davarci, Sena Ece; Mocan, Eda Eylemer; Acar, Omer; Isik, Deniz; Aydin, Esra; Karakas, Yusuf; Ozcelik, Melike; Keser, Murat; Okutur, Sadi Kerem; Eren, Onder; Menekse, Serkan; Aydin, Dincer; Yilmaz, Funda; Dogan, Ozlem; Ozkanli, Gulhan; Yucel, Hakan; Sunar, Veli; Aykan, Musa Baris; Ozdemir, Ozlem; Duman, Berna Bozkurt; Keskinkilic, Merve; Sakalar, Teoman; Inal, Ali; Karaoglanoglu, Muge; Aksoy, Asude; Er, Muhammed Muhiddin; Turhal, Nazim Serdar; Kalkan, Nurhan Onal; Sendur, Mehmet Ali Nahit

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study

免疫疗法和化疗免疫疗法治疗晚期罕见肿瘤患者的疗效:土耳其肿瘤协作组(TOG)研究

Guven, Deniz Can; Aykan, Musa Baris; Muglu, Harun; Bayram, Ertugrul; Helvaci, Kaan; Dursun, Bengü; Celayir, Melisa; Chelebiyev, Elvin; Nayir, Erdinc; Erman, Mustafa; Sezer, Ahmet; Urun, Yuksel; Demirci, Umut; Er, Ozlem; Disel, Umut; Bilici, Ahmet; Arslan, Cagatay; Karadurmus, Nuri; Kilickap, Saadettin

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

瑞戈非尼治疗难治性转移性结直肠癌患者的预后因素:一项真实世界的回顾性多中心研究

Goktas Aydin, Sabin; Kavak, Engin Eren; Topcu, Atakan; Bayramgil, Ayberk; Akgul, Fahri; Kahraman, Seda; Aykan, Musa Baris; Altıntas, Yunus Emre; Helvaci, Kaan; Urun, Yuksel; Bilici, Ahmet; Seker, Mesut; Sendur, Mehmet Ali Nahit; Olmez, Omer Fatih; Acikgoz, Ozgur; Cicin, Irfan

Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

在接受积极全身治疗的癌症患者中,CoronaVac疫苗的免疫原性和安全性

Karacin, Cengiz; Eren, Tulay; Zeynelgil, Esra; Imamoglu, Goksen Inanc; Altinbas, Mustafa; Karadag, Ibrahim; Basal, Fatma Bugdayci; Bilgetekin, Irem; Sutcuoglu, Osman; Yazici, Ozan; Ozdemir, Nuriye; Ozet, Ahmet; Yildiz, Yesim; Esen, Selin Akturk; Ucar, Gokhan; Uncu, Dogan; Dinc, Bedia; Aykan, Musa Baris; Erturk, İsmail; Karadurmus, Nuri; Civelek, Burak; Çelik, İsmail; Ergun, Yakup; Dogan, Mutlu; Oksuzoglu, Omur Berna